Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1134515

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1134515

Nicotine Patch Market: Current Analysis and Forecast (2022-2028)

PUBLISHED:
PAGES: 124 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License)
USD 5499
PDF (Global License)
USD 6999

Add to Cart

Global Nicotine Patch Market is expected to grow at a significant rate of around 7% during the forecast period. This growth can be due to growing awareness among the population regarding the benefits of using the nicotine patch over gums or lozenges. Nicotine patches can provide a steady level of nicotine in the body which helps in reducing smoking withdrawal as compared to gum or lozenge can be used to relieve cravings more quickly as they happen. Furthermore, growing anti-smoking government & international organization initiatives, increased adoption of nicotine patches for smoking cessation, and the launch of new products in the market by the industry players are some of the prominent factors contributing to the growth of the market globally. For example, in January 2018, Cipla Health, an arm of Cipla with a focus on consumer healthcare products, launched Nicotex Nicotine patches to help smokers kick the habit in 12 weeks. Nicotex Nicotine patch is a skin/transdermal patch that works on the proven principle of nicotine replacement therapy.

GlaxoSmithKline plc, Novartis AG, Dr. Reddy's Laboratories Ltd., Perrigo Company plc, Johnson & Johnson Services, Inc., Cipla Health Ltd., Cigna, Habitrol, CVS Health Corp, Rusan Pharma Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with nicotine patch.

Insights Presented in the Report:

"Amongst product, 24-hour nicotine patch category to witness higher CAGR during the forecast period"

Based on the product, the nicotine patch market is segmented into 24-hour nicotine patch and 16-hour nicotine patch. The 24-hour nicotine patch segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to rising demand for these patches in different variants such as 7mg, 14 mg, and 21 mg. Furthermore, the 24-hour nicotine patch are more effective than 16-hour nicotine patch in reducing the positive reinforcing dimension of smoking urges which is also driving the growth of this segment.

"Amongst distribution channels, the offline segment to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is fragmented into online and offline. Among these, the offline segment held a significant share in the market in 2020. This is mainly due to the wide availability of nicotine patches in various retail chains and the increasing preference of smokers to buy them from retail stores. However, the online segment is expected to witness significant growth owing to the rise in the number of internet users globally and the buy-it-now attitude of users.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the nicotine patch industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure and the rising burden of diseases caused due to smoking such as lung diseases, cancer, stroke, and heart diseases, among others. For instance, according to the American Lung Association, almost 37 million Americans live with chronic lung diseases like asthma and COPD, which include emphysema and chronic bronchitis. Furthermore, an increase in government initiatives and the growing adoption of these patches are also driving the market.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global nicotine patch market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Product Code: UMHE211159

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Nicotine Patch Market
  • 2.2. Research Methodology of the Nicotine Patch Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE NICOTINE PATCH MARKET

6 NICOTINE PATCH MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. 24-hour nicotine patch
  • 7.2. 16-hour nicotine patch

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 8.1. Online
  • 8.2. Offline

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 NICOTINE PATCH MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 NICOTINE PATCH MARKET OPPORTUNITIES

12 NICOTINE PATCH MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. GlaxoSmithKline plc
  • 16.2. Novartis AG
  • 16.3. Dr. Reddy's Laboratories Ltd.
  • 16.4. Perrigo Company plc
  • 16.5. Johnson & Johnson Services, Inc.
  • 16.6. Cipla Health Ltd.
  • 16.7. Cigna
  • 16.8. Habitrol
  • 16.9. CVS Health Corp
  • 16.10. Rusan Pharma Ltd.

17 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!